Fulgent Genetics, Inc. (FLGT) to Acquire CSI Laboratories
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Fulgent Genetics, Inc. (FLGT) Misses Q2 EPS by 26c
August 9, 2021 4:12 PM EDTFulgent Genetics, Inc. (NASDAQ: FLGT) reported Q2 EPS of $2.55, $0.26 worse than the analyst estimate of $2.81. Revenue for the quarter came in at $153.6 million versus the consensus estimate of $197.34 million.
GUIDANCE:
Fulgent Genetics, Inc. sees FY2021 EPS of $12.50, versus the consensus of... More
